The price of immunity

Nature Immunology

Volumn 13, Issue 10, 2012, Pages 932-938

  Goldszmid, Romina S ^a   Trinchieri, Giorgio ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; COMMENSALISM; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; MICROBIAL COLONIZATION; NEGATIVE FEEDBACK; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVIEW; SYMBIOSIS; TISSUE INJURY;

ADAPTIVE IMMUNITY; ANIMALS; CHEMOKINES; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; METAGENOME; SYMBIOSIS; T-LYMPHOCYTE SUBSETS;

EID: 84866528138     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2422     Document Type: Review

References (117)

1. Germain, R.N. Maintaining system homeostasis: the third law of Newtonian immunology. Nat. Immunol. 13, 902-906 (2012).
2. Banchereau, J., Pascual, V. & O'Garra, A. From IL-2 to IL-37: a tale of anti-infammatory cytokines. Nat. Immunol. 13, 925-931 (2012).
3. Murray, P.J. & Smale, S.T. Restraint of infammatory signaling by interdependent strata of negative regulatory pathways. Nat. Immunol. 13, 916-924 (2012).
4. Hooper, L.V., Littman, D.R. & Macpherson, A.J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012).
5. Naik, S. et al. Compartmentalized control of skin immunity by resident commensals. Science advance online publication, doi:10.1126/science.1225152 (26 July 2012).
6. Matzinger, P. & Kamala, T. Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 11, 221-230 (2011).
7. Raz, E. Organ-specifc regulation of innate immunity. Nat. Immunol. 8, 3-4 (2007).
8. Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nat. Immunol. 8, 11-13 (2007). (Pubitemid 46242350)
9. Cohn, M. Meanderings into the regulation of effector class by the immune system: derivation of the trauma model. Scand. J. Immunol. 76, 77-88 (2012).
10. Trinchieri, G. Cancer and infammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 30, 677-706 (2012).
11. Schenten, D. & Medzhitov, R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 109, 87-124 (2011).
12. Streilein, J.W. Pathologic lesions of GVH disease in hamsters: antigenic target versus 'innocent bystander'. Prog. Exp. Tumor Res. 16, 396-408 (1972).
13. Elson, C.O., Reilly, R.W. & Rosenberg, I.H. Small intestinal injury in the graft versus host reaction: an innocent bystander phenomenon. Gastroenterology 72, 886-889 (1977). (Pubitemid 8093899)
14. Stearns-Kurosawa, D.J., Osuchowski, M.F., Valentine, C., Kurosawa, S. & Remick, D.G. The pathogenesis of sepsis. Annu. Rev. Pathol. 6, 19-48 (2011).
15. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002). (Pubitemid 34303674)
16. Medzhitov, R. Origin and physiological roles of infammation. Nature 454, 428-435 (2008).
17. Nish, S. & Medzhitov, R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 34, 629-636 (2011).
18. Martin, B., Ji, S., Maudsley, S. & Mattson, M.P. "Control" laboratory rodents are metabolically morbid: why it matters. Proc. Natl. Acad. Sci. USA 107, 6127-6133 (2010).
19. Bowcock, A.M. Genome-wide association studies and infectious disease. Crit. Rev. Immunol. 30, 305-309 (2010).
20. Vannberg, F.O., Chapman, S.J. & Hill, A.V. Human genetic susceptibility to intracellular pathogens. Immunol. Rev. 240, 105-116 (2011).
21. Rock, K.L., Lai, J.J. & Kono, H. Innate and adaptive immune responses to cell death. Immunol. Rev. 243, 191-205 (2011).
22. Rock, K.L., Latz, E., Ontiveros, F. & Kono, H. The sterile infammatory response. Annu. Rev. Immunol. 28, 321-342 (2010).
23. Takeuchi, O. & Akira, S. Pattern recognition receptors and infammation. Cell 140, 805-820 (2010).
24. Marichal, T. et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat. Med. 17, 996-1002 (2011).
25. Barbalat, R., Ewald, S.E., Mouchess, M.L. & Barton, G.M. Nucleic acid recognition by the innate immune system. Annu. Rev. Immunol. 29, 185-214 (2011).
26. Molloy, M.J., Bouladoux, N. & Belkaid, Y. Intestinal microbiota: shaping local and systemic immune responses. Semin. Immunol. 24, 58-66 (2012).
27. Ivanov, I.I. & Littman, D.R. Segmented flamentous bacteria take the stage. Mucosal Immunol. 3, 209-212 (2010).
28. Garrett, W.S. et al. Colitis-associated colorectal cancer driven by T-bet defciency in dendritic cells. Cancer Cell 16, 208-219 (2009).
29. Allen, I.C. et al. The NLRP3 infammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045-1056 (2010).
30. Salcedo, R. et al. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207, 1625-1636 (2010).
31. Henao-Mejia, J. et al. Infammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012).
32. Garrett, W.S. et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8, 292-300 (2010).
33. Elinav, E. et al. NLRP6 infammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
34. Lathrop, S.K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250-254 (2011).
35. Hand, T.W. et al. Acute gastrointestinal infection induces long-lived microbiota-specifc T cell responses. Science advance online publication, doi:10.1126/science.1220961 (23 August 2012).
36. Kaser, A., Zeissig, S. & Blumberg, R.S. Infammatory bowel disease. Annu. Rev. Immunol. 28, 573-621 (2010).
37. Abraham, C. & Cho, J.H. Infammatory bowel disease. N. Engl. J. Med. 361, 2066-2078 (2009).
38. Hviid, A., Svanstrom, H. & Frisch, M. Antibiotic use and infammatory bowel diseases in childhood. Gut 60, 49-54 (2011).
39. Barrett, J.C. et al. Genome-wide association defnes more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
40. Fritz, T., Niederreiter, L., Adolph, T., Blumberg, R.S. & Kaser, A. Crohn's disease: NOD2, autophagy and ER stress converge. Gut 60, 1580-1588 (2011).
41. Ahern, P.P., Izcue, A., Maloy, K.J. & Powrie, F. The interleukin-23 axis in intestinal infammation. Immunol. Rev. 226, 147-159 (2008).
42. Abraham, C. & Cho, J.H. IL-23 and autoimmunity: new insights into the pathogenesis of infammatory bowel disease. Annu. Rev. Med. 60, 97-110 (2009).
43. Glocker, E.O., Kotlarz, D., Klein, C., Shah, N. & Grimbacher, B. IL-10 and IL-10 receptor defects in humans. Ann. NY Acad. Sci. 1246, 102-107 (2011).
44. -/- mice: insuffcient counter regulation of a Th1 response. Int. Rev. Immunol. 19, 91-121 (2000). (Pubitemid 30146945)
45. Fry, L. & Baker, B.S. Triggering psoriasis: the role of infections and medications. Clin. Dermatol. 25, 606-615 (2007). (Pubitemid 350087607)
46. Fahlén, A., Engstrand, L., Baker, B.S., Powles, A. & Fry, L. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch. Dermatol. Res. 304, 15-22 (2012).
47. Grice, E.A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192 (2009).
48. Valdimarsson, H., Thorleifsdottir, R.H., Sigurdardottir, S.L., Gudjonsson, J.E. & Johnston, A. Psoriasis-as an autoimmune disease caused by molecular mimicry. Trends Immunol. 30, 494-501 (2009).
49. Brenchley, J.M. & Douek, D.C. Microbial translocation across the GI tract. Annu. Rev. Immunol. 30, 149-173 (2012).
50. Kamat, A., Ancuta, P., Blumberg, R.S. & Gabuzda, D. Serological markers for infammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS ONE 5, e15533 (2010).
51. Jiang, W. et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199, 1177-1185 (2009).
52. Brenchley, J.M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006). (Pubitemid 44924494)
53. Sandler, N.G. & Douek, D.C. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat. Rev. Microbiol. 10, 655-666 (2012).
54. + lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. advance online publication, doi:10.1038/mi.2012.38 (30 May 2012).
55. Després, J.P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881-887 (2006). (Pubitemid 46024995)
56. Burcelin, R., Garidou, L. & Pomie, C. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Semin. Immunol. 24, 67-74 (2012).
57. Kanneganti, T.D. & Dixit, V.D. Immunological complications of obesity. Nat. Immunol. 13, 707-712 (2012).
58. Donohoe, C.L., Ryan, A.M. & Reynolds, J.V. Cancer cachexia: mechanisms and clinical implications. Gastroenterol. Res. Pract. 2011, 601434 (2011).
59. + T cells in the control of cachexia. J. Immunol. 181, 4676-4684 (2008).
60. Chervonsky, A.V. Intestinal commensals: infuence on immune system and tolerance to pathogens. Curr. Opin. Immunol. 24, 255-260 (2012).
61. Taurog, J.D., Richardson, J.A., Croft, J.T., Simmons, W.A. & Zhou, M. The germfree state prevents development of gut and joint infammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359-2364 (1994). (Pubitemid 24351619)
62. Wu, H.J. et al. Gut-residing segmented flamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
63. Ochoa-Repáraz, J. et al. Role of gut commensal microfora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183, 6041-6050 (2009).
64. Ochoa-Repáraz, J., Mielcarz, D.W., Haque-Begum, S. & Kasper, L.H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microfora. Gut Microbes 1, 103-108 (2010).
65. Lee, Y.K., Menezes, J.S., Umesaki, Y. & Mazmanian, S.K. Proinfammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108 (suppl. 1), 4615-4622 (2011).
66. Yanagisawa, N., Haruta, I., Kikuchi, K., Shibata, N. & Yagi, J. Are dysregulated infammatory responses to commensal bacteria involved in the pathogenesis of hepatobiliary-pancreatic autoimmune disease? An analysis using mice models of primary biliary cirrhosis and autoimmune pancreatitis. ISRN Gastroenterol. published online, doi:10.5402/2011/513514 (15 June 2011).
67. Brandon, J.A., Jennings, C.D., Kaplan, A.M. & Bryson, J.S. Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy. J. Immunol. 186, 3726-3734 (2011).
68. Wen, L. et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455, 1109-1113 (2008).
69. Ichinohe, T. et al. Microbiota regulates immune defense against respiratory tract infuenza A virus infection. Proc. Natl. Acad. Sci. USA 108, 5354-5359 (2011).
70. Abt, M.C. et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158-170 (2012).
71. Ma, X. & Trinchieri, G. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 79, 55-92 (2001). (Pubitemid 32977574)
72. Aste-Amezaga, M., Ma, X., Sartori, A. & Trinchieri, G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160, 5936-5944 (1998). (Pubitemid 28298054)
73. Gerosa, F. et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205, 1447-1461 (2008). (Pubitemid 351831499)
74. Wirtz, S., Billmeier, U., McHedlidze, T., Blumberg, R.S. & Neurath, M.F. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141, 1875-1886 (2011).
75. Laouar, Y., Sutterwala, F.S., Gorelik, L. & Flavell, R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 6, 600-607 (2005). (Pubitemid 41710731)
76. + T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J. Exp. Med. 204, 2591-2602 (2007). (Pubitemid 350044785)
77. Goldszmid, R.S. et al. NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 36, 1047-1059 (2012).
78. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 157, 798-805 (1996). (Pubitemid 26231385)
79. Egan, C.E., Cohen, S.B. & Denkers, E.Y. Insights into infammatory bowel disease using Toxoplasma gondii as an infectious trigger. Immunol. Cell Biol. 90, 668-675 (2011).
80. Heimesaat, M.M. et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J. Immunol. 177, 8785-8795 (2006). (Pubitemid 44893845)
81. Muñoz, M. et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206, 3047-3059 (2009).
82. Benson, A., Pifer, R., Behrendt, C.L., Hooper, L.V. & Yarovinsky, F. Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe 6, 187-196 (2009).
83. + innate lymphoid cells control Intestinal infammation by recruiting infammatory monocytes. Immunity 37, 108-121 (2012).
84. Craven, M. et al. Infammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS ONE 7, e41594 (2012).
85. Braciale, T.J., Sun, J. & Kim, T.S. Regulating the adaptive immune response to respiratory virus infection. Nat. Rev. Immunol. 12, 295-305 (2012).
86. Teijaro, J.R. et al. Endothelial cells are central orchestrators of cytokine amplifcation during infuenza virus infection. Cell 146, 980-991 (2011).
87. Lin, K.L., Suzuki, Y., Nakano, H., Ramsburg, E. & Gunn, M.D. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce infuenza-induced pulmonary immune pathology and mortality. J. Immunol. 180, 2562-2572 (2008).
88. Trinchieri, G. Type I interferon: friend or foe? J. Exp. Med. 207, 2053-2063 (2010).
89. Shahangian, A. et al. Type I IFNs mediate development of postinfuenza bacterial pneumonia in mice. J. Clin. Invest. 119, 1910-1920 (2009).
90. Navarini, A.A. et al. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl. Acad. Sci. USA 103, 15535-15539 (2006). (Pubitemid 44625627)
91. Rayamajhi, M., Humann, J., Kearney, S., Hill, K.K. & Lenz, L.L. Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections. Virulence 1, 418-422 (2010).
92. Ling, P.D., Warren, M.K. & Vogel, S.N. Antagonistic effect of interferon-β on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J. Immunol. 135, 1857-1863 (1985). (Pubitemid 16242999)
93. Snelgrove, R.J. et al. A critical function for CD200 in lung immune homeostasis and the severity of infuenza infection. Nat. Immunol. 9, 1074-1083 (2008).
94. Goulding, J. et al. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J. Infect. Dis. 204, 1086-1094 (2011).
95. Gautier, G. et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201, 1435-1446 (2005). (Pubitemid 40664087)
96. Byrnes, A.A. et al. Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity. Eur. J. Immunol. 31, 2026-2034 (2001). (Pubitemid 32640718)
97. Karp, C.L. et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231 (1996). (Pubitemid 26285887)
98. Noone, CM. et al. Novel mechanism of immunosuppression by infuenza virus haemagglutinin: selective suppression of interleukin 12 p35 transcription in murine bone marrow-derived dendritic cells. J. Gen. Virol. 86, 1885-1890 (2005). (Pubitemid 40916371)
99. Negishi, H. et al. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat. Immunol. 13, 659-666 (2012).
100. Kane, M. et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334, 245-249 (2011).
101. Kuss, S.K. et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334, 249-252 (2011).
102. Jude, B.A. et al. Subversion of the innate immune system by a retrovirus. Nat Immunol. 4, 573-578 (2003). (Pubitemid 36701341)
103. Cadwell, K. et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145 (2010).
104. Barber, D.L., Andrade, B.B., Sereti, I. & Sher, A. Immune reconstitution infammatory syndrome: the trouble with immunity when you had none. Nat. Rev Microbiol. 10, 150-156 (2012).
105. Müller, M. et al. Immune reconstitution infammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect. Dis. 10, 251-261 (2010).
106. Keane, J. et al. Tuberculosis associated with infiximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345, 1098-1104 (2001).
107. Khatri, B.O. et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72, 402-409 (2009).
108. Sun, H.Y. & Singh, N. Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. Clin. Infect. Dis. 53, 168-176 (2011).
109. Leonard, J.P. et al. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-y production. Blood 90, 2541-2548 (1997). (Pubitemid 27413462)
110. Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018-1028 (2006). (Pubitemid 44343545)
111. Hodi, F.S. et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc. Natl. Acad. Sci. USA 105, 3005-3010 (2008). (Pubitemid 351723658)
112. Chisari, F.V., Isogawa, M. & Wieland, S.F. Pathogenesis of hepatitis B virus infection. Pathol. Biol. (Paris) 58, 258-266 (2010).
113. Fallot, G., Neuveut, C. & Buendia, M.A. Diverse roles of hepatitis B virus in liver cancer. Curr. Opin Virol. 2, 467-473 (2012).
114. Fung, J., Lai, C.L. & Yuen, M.F. Hepatitis B and C virus-related carcinogenesis. Clin. Microbiol. Infect. 15, 964-970 (2009).
115. McGivern, D.R. & Lemon, S.M. Virus-specifc mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30, 1969-1983 (2011).
116. Moore, P.S. & Chang, Y. Why do viruses cause cancer? Highlights of the frst century of human tumour virology. Nat. Rev. Cancer 10, 878-889 (2010).
117. Dolberg, D.S., Hollingsworth, R., Hertle, M. & Bissell, M.J. Wounding and its role in RSV-mediated tumor formation. Science 230, 676-678 (1985). (Pubitemid 16190963)